FDA: Depo-Provera Labels Must Warn of Meningioma Risk December 22, 2025 Labels for Pfizer’s Depo-Provera contraceptive injection must now warn of the risk of meningioma, a type of brain tumor. The U.S. Food and Drug Administration (FDA) required the label change last week. The warning applies to two injectable forms of the drug, Depo-Provera CI and Depo-Subq Provera 104, which consist of progestin, a synthetic form […] Read More
Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) December 17, 2025 Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) The U.S. Judicial Panel on Multidistrict Litigation has ordered the creation of a new federal multidistrict litigation consolidating lawsuits alleging that popular GLP-1 receptor agonist drugs caused patients to suffer serious vision injuries, including non-arteritic anterior ischemic optic neuropathy, […] Read More
New Study Links Depo-Provera to Higher Risk of Brain Tumor October 6, 2025 A new study published in JAMA Neurology in September 2025 found that women in the United States who use the birth control shot Depo-Provera (depot medroxyprogesterone acetate, or DMPA) may face a higher risk of developing meningioma, a type of brain tumor that forms in the membranes surrounding the brain and spinal cord. Key Findings […] Read More
Levin Law
Levin Law